The Alzheimer Society of Ireland (ASI)’s response to the announcement of results around lecanemab, at the annual Clinical Trials in Alzheimer’s Disease (CTAD) conference in San Francisco was widely reported by the Irish Media. The ASI Research and Policy Manager Dr Laura O’Philbin (pictured, left) and Vice-Chair of the Irish Dementia Working Group Helen Rochford-Brennan (pictured, right) were interviewed by the National Broadcaster RTÉ for their nightly news, and they appeared on many other national radio stations.
Pictured, left: Dr Laura O'Philbin (right) on The Tonight Show on Virgin Media One
Pictured, right: Vice Chair of Irish Dementia Working Group Helen Rochford-Brennan on RTÉ Six One News
